PI-LBA 01: Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Overactive Bladder
Presenter: Cindy L. Amundsen ,M.D.
PI-LBA 02: Reevaluating PSA testing rates in the PLCO trial
Presenter: Jonathan Shoag, MD
PI-LBA 04: Hemiablation HIFU for Unilateral Localized Prostate Cancer: a Prospective Multicenter Trial
Presenter: Pascal Jean Rischmann ,M.D., Ph.D.
PI-LBA 05: Understanding the Sexual Habits of Men Taking Medication for Erectile Dysfunction (ED): Survey Results From 7 Countries
Presenter: John P. Mulhall, MD
PI-LBA 06: VA CSP#553 Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma: A Phase III Randomized Study
Presenter: Daniel W. Lin, MD
PI-LBA 07: The Development and Clinical Validation of a High Sensitivity Urine biomarker test for the Determination of Recurrence in Urothelial Carcinoma Patients
Presenter: Yair Lotan, MD
PI-LBA 08: Preliminary Assessment of a Validated Urine Exosome Assay (ExDx Prostate (IntelliScore) for Predicting Biochemical Recurrence Post-Prostatectomy
Presenter: Michael Lipsky, MD
PI-LBA 09: IsoPSA: Initial Clinical Performance Evaluation of a Novel Structure-Based Biomarker For Prostate Cancer in a Multicenter Prospective Trial for Gleason = 7
Presenter: Eric A. Klein, MD